Refractory Hodgkin lymphoma: time for targeted therapies?

被引：1
|
作者：
Brice, Pauline [1 ]
机构：
[1] Hop St Louis, Paris, France
来源：
BLOOD | 2018年 / 131卷 / 11期
关键词：
BRENTUXIMAB VEDOTIN; PHASE-II; SINGLE;
D O I：
10.1182/blood-2017-12-824136
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
With the use of targeted therapies in classical Hodgkin lymphoma (HL), the paradigm of salvage chemotherapy followed by autotransplant may have changed. In this issue of Blood, Herrera et al report positive results using targeted therapy for salvage treatment before autotransplantation.(1)
引用
收藏
页码：1156 / 1157
页数：4
相关论文
共 50 条
  • [21] Therapy of relapsed and refractory Hodgkin Lymphoma
    von Tresckow, B.
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 62 - 62
  • [22] Managing relapsed and refractory Hodgkin lymphoma
    Brice, Pauline
    BRITISH JOURNAL OF HAEMATOLOGY, 2008, 141 (01) : 3 - 13
  • [23] Pembrolizumab for relapsed or refractory Hodgkin lymphoma
    Pulsoni, Alessandro
    LANCET ONCOLOGY, 2020, 22 (06): : E234 - E234
  • [24] Synchronous Hodgkin's lymphoma and schwannomas mimicking refractory Hodgkin's lymphoma
    Leeksma, Onno C.
    Haas, Rick L. M.
    Hofman, Frederik N.
    Hulsebos, Theo J.
    van Os, Theo A. M.
    de la Riviere, Aart Brutel
    ANNALS OF HEMATOLOGY, 2015, 94 (09) : 1593 - 1595
  • [25] Synchronous Hodgkin’s lymphoma and schwannomas mimicking refractory Hodgkin’s lymphoma
    Onno C. Leeksma
    Rick L. M. Haas
    Frederik N. Hofman
    Theo J. Hulsebos
    Theo A. M. van Os
    Aart Brutel de la Rivière
    Annals of Hematology, 2015, 94 : 1593 - 1595
  • [26] Relapsed/Refractory Classical Hodgkin Lymphoma
    Winter, Jane N.
    TURKISH JOURNAL OF HEMATOLOGY, 2023, 40 : 34 - 35
  • [27] Treatment of Relapsed/Refractory Hodgkin Lymphoma
    Chen, Robert W.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2015, 13 (02) : 6 - 9
  • [28] Advances in CD30- and PD-1-targeted therapies for classical Hodgkin lymphoma
    Yucai Wang
    Grzegorz S. Nowakowski
    Michael L. Wang
    Stephen M. Ansell
    Journal of Hematology & Oncology, 11
  • [29] Treatment of relapsed and refractory Hodgkin Lymphoma
    von Tresckow, Bastian
    Moskowitz, Craig H.
    SEMINARS IN HEMATOLOGY, 2016, 53 (03) : 180 - 185
  • [30] Metronomic chemotherapy regimens and targeted therapies in non-Hodgkin lymphoma: The best of two worlds
    Cox, Maria Christina
    Bocci, Guido
    CANCER LETTERS, 2022, 524 : 144 - 150
12345